chitosan based vaccine adjuvant (Zonagen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namechitosan based vaccine adjuvant (Zonagen)
Drug Alias NameChito-ZNImmuMaxchitosan based vaccine adjuvant (Repros Therapeutics)Z-216
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRepros Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRepros Therapeutics Inc
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A